Ignite Creation Date:
2024-05-05 @ 4:50 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00329901
Status:
COMPLETED
Last Update Posted:
2014-06-18
First Post:
2006-05-23
Brief Title:
Immunogenicity and Safety of the Concomitant Administration of a Tdap Vaccine and Meningococcal ACWY Conjugate Vaccine in Healthy Subjects Aged 11-25 Years
Sponsor:
Novartis Vaccines
Organization:
Novartis
Study Overview
Official Title:
A Phase 3 Multi-Center Observer Blind Controlled Randomized Study to Compare the Immunogenicity and Safety of the Concomitant Administration of a Combined Tetanus Reduced Diphtheria and Acellular Pertussis Tdap Vaccine and Chiron Now Novartis Meningococcal ACWY Conjugate Vaccine With Either One Dose of Acellular Pertussis Tdap Vaccine or One Dose of Chiron Now Novartis Meningococcal ACWY Conjugate Vaccine in Healthy Subjects Aged 11-25 Years
Status:
COMPLETED
Status Verified Date:
2014-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Immunogenicity and Safety of the Concomitant Administration of a Tdap Vaccine and Meningococcal ACWY Conjugate Vaccine in Healthy Subjects Aged 11-25 Years
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2005-005519-12 | EUDRACT_NUMBER | None | None |